EW Q1 2022 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$50B

Q1 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.3B+10.2% YoY

Gross Profit

$1.0B77.1% margin

Operating Income

$436M32.5% margin

Net Income

$374M27.9% margin

EPS (Diluted)

$0.59

QoQ Revenue Growth

+0.9%

Cash Flow

Operating Cash Flow

$293M

Free Cash Flow

$221M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$8.4B

Total Liabilities

$2.6B

Stockholders' Equity

$5.8B

Cash & Equivalents

$1.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.3B	$1.2B	+10.2%
Gross Profit	$1.0B	$929M	+11.4%
Operating Income	$436M	$391M	+11.5%
Net Income	$374M	$338M	+10.5%

Revenue Segments

Transcatheter Heart Valves

$881M66%

Surgical Heart Valve Therapy

$221M16%

Critical Care

$212M16%

Transcatheter Mitral And Tricuspid Therapies

$27M2%

Geographic Segments

UNITED STATES

$750M56%

Europe

$311M23%

Rest of World

$145M11%

JAPAN

$136M10%